Allogene Therapeutics, Inc.

Form 144 Allogene Therapeutics For: 21 October By Investing.com
Investing.com South Africa · 22 Oct 2026
Form 144 Allogene Therapeutics For: 21 October
Investing.com India · 22 Oct 2026
An officer proposes selling 36,342 Allogene Therapeutics (NASDAQ: ALLO) shares after stock vesting.
Stock Titan · 21 Oct 2026
ALLO News | ALLOGENE THERAPEUTICS INC (NASDAQ:ALLO)
ChartMill · 17 Oct 2026
We're Not Very Worried About Allogene Therapeutics' (NASDAQ:ALLO) Cash Burn Rate
Simply Wall Street · 03 Oct 2026
At $1.55 a share, TPG funds sold Allogene Therapeutics (ALLO) stock.
Stock Titan · 30 Sep 2026
TPG Fully Divests Stake in Allogene Therapeutics, Reports Zero Ownership
Kalkine Media · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.